NCT07289243 is a NA clinical trial of ECHOLASER-TPLA in RANDOMIZED, sponsored by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari.

Who is sponsoring NCT07289243?

NCT07289243 is sponsored by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari.

What drugs are being tested in NCT07289243?

Interventions in NCT07289243: ECHOLASER-TPLA, TURP.

What condition does NCT07289243 study?

NCT07289243 studies RANDOMIZED.

Is NCT07289243 still recruiting?

NCT07289243 is currently recruiting now. Last updated 17 December 2025.

Last reviewed 2025-12-17 · How we verify

NCT07289243

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RANDOMIZED CLINICAL TRIAL COMPARING TRANSURETHRAL PROSTATE RESECTION (TURP) AND ECHOLASER SORACTELITE-TPLA (TRANSPERINEAL LASER ABLATION) IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC OBSTRUCTION

Recruiting now NA Last updated 17 December 2025

What this trial tests

NA trial testing ECHOLASER-TPLA in RANDOMIZED in 80 participants. Currently enrolling.

Timeline

14 July 2024

Primary endpoint
25 December 2025

25 December 2026

Quick facts

Lead sponsor	Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	80
Start date	14 July 2024
Primary completion	25 December 2025
Estimated completion	25 December 2026
Sites	2 locations across Italy

Drugs / interventions tested

ECHOLASER-TPLA
TURP

Conditions studied

RANDOMIZED — all drugs for RANDOMIZED →

Sponsor

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Who can join

Adults 40 to 85, male only, with RANDOMIZED. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

THIS STUDY IS A RANDOMIZED CLINICAL TRIAL COMPARING TRANSURETHRAL PROSTATE RESECTION (TURP) AND ECHOLASER SORACTELITE-TPLA (TRANSPERINEAL LASER ABLATION) IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC OBSTRUCTION. THE PRIMARY GOAL IS TO SHOW THE NON-INFERIORITY OF TPLA VERSUS TURP BY IPSS-SCORE.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari trials

Trials by the same sponsor.

NCT06812611 — Effects of High Intensity Laser Therapy in Muscle Injuries · NA · recruiting
NCT07566507 — High-Energy Laser in the Conservative Treatment of Rhizarthrosis · NA · recruiting
NCT06833372 — Shock Waves in Knee Arthritis · NA · recruiting
NCT06737601 — ESWT vs Orthosis in Trigger Finger · NA · not yet recruiting
NCT07185555 — Vey Low-Energy Ketogenic Therapy in Adults With Type 1 Diabetes and Obesity on Intensive Insulin Therapy Using Advanded · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07289243 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Last refreshed: 17 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07289243.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing